In the dynamic landscape of the Australian Stock Exchange (ASX), two prominent players have caught the attention of investors – CSL Limited (ASX:CSL) and Woolworths Group Ltd (ASX:WOW). As of the start of 2023, CSL has witnessed a 0.8% uptick in its share price, while Woolworths sits 9% below its 52-week high. This article aims to explore why considering CSL and WOW shares for your investment watchlist could be a prudent move.


Image Credit: Pexels

CSL Limited: A Global Biotech Powerhouse


CSL Limited operates as a global biotechnology company, specializing in developing and delivering innovative medicines that save lives and enhance public health. The company is structured into three main business units: CSL Behring, CSL Seqirus, and CSL Vifor.


- CSL Behring: Acquired in 2004, focuses on manufacturing and distributing blood plasma products.

- CSL Seqirus: Formed by rebranding BioCSL and acquiring Novartis flu business in 2015, specializes in flu-related products and pandemic-related services for governments.

- CSL Vifor: Produces products for iron deficiency and nephrology (renal/kidney care).


CSL's plasma collection unit plays a crucial role in creating life-saving treatments globally. The company's reliance on plasma and blood collections is central to its core business, with strategic acquisitions further bolstering its position. Investors often view CSL as an indirect play on increasing healthcare spending.


For mature businesses like CSL, factors like Return on Invested Capital (ROIC) and revenue growth become crucial indicators of sustainability. In FY23, CSL Limited demonstrated an ROIC of 10.30%, and its revenue has compounded at an impressive 8.7% in recent years. With an ROIC exceeding 10%, CSL remains a robust choice for investors in the mature business sector.


Woolworths Group Ltd: A Retail Giant


Established in 1924, Woolworths stands tall as a retail giant in Australia and New Zealand, operating over 3,000 stores and employing more than 100,000 individuals. As the largest company in Australia concerning revenue and market share, Woolworths operates supermarkets under its brand in Australia and Countdown in New Zealand, alongside discount department stores under the Big W brand and B2B brands like PFD.


Woolworths is a favored choice for ASX investors seeking dividend income. The company consistently pays fully franked dividends, typically yielding over 3%, providing a defensive earnings stream. Its competitive edge lies in its scale, offering efficiency in distribution and low costs, and proximity, meeting the shopping needs of a significant portion of the population.


Share Price Valuation Insights


Understanding the valuation of CSL and Woolworths shares is crucial for investors. Currently, CSL Limited shares exhibit a dividend yield of approximately 1.27%, slightly surpassing its 5-year average of 1.24%. This suggests that CSL shares are trading below their historical average dividend yield.


On the other hand, Woolworths, being a more mature business, presents a historical dividend yield of around 2.83%, outperforming its 5-year average of 2.66%. For investors looking for comprehensive valuation methods, exploring Discounted Cash Flow (DCF) and Dividend Discount Models (DDM) through platforms like Rask Education could provide a more nuanced understanding of Woolworths' share price.


In conclusion, both CSL Limited and Woolworths Group Ltd offer unique investment propositions. CSL's global presence in biotechnology and Woolworths' dominance in the retail sector make them compelling candidates for your investment watchlist. As with any investment decision, thorough research and consideration of your financial goals are essential before adding these stocks to your portfolio.